Visine

Visine (/ˌvaɪˈziːn/), also known as Vispring, is a brand of eye drops produced by Kenvue. Visine was first introduced in 1958 and was acquired by Pfizer in 1999. In 2006, Johnson & Johnson acquired Visine, along with Pfizer's entire consumer healthcare portfolio. The original formulation of Visine includes the active ingredient tetrahydrozoline hydrochloride, which is a vasoconstrictor that constricts the eye's superficial blood vessels to temporarily reduce eye redness.